Acne Treatment

Advanced acne management using radiofrequency sebaceous gland ablation (Agnes), Vbeam laser, Q-Switch, and HydraFacial, with the clinic reporting a 90% patient response rate for significant improvement.

The Clifford Clinic reports that 90% of patients treated in their acne programme achieve a significant improvement, reflecting the breadth of their treatment toolkit and the experience of their physicians in selecting and combining modalities based on acne type, severity, and skin characteristics. AGNES Radiofrequency is the clinic's signature acne procedure. Using ultra-fine insulated microneedles, AGNES delivers targeted radiofrequency energy directly into individual sebaceous glands, permanently reducing their activity without damaging the surrounding skin. Because sebum overproduction is the root cause of most acne, reducing gland activity at source creates a long-lasting reduction in breakouts rather than temporary suppression. Multiple sessions are needed, spaced four to six weeks apart. Gold Photothermal Therapy (GTP) is a complementary approach that introduces gold nanoparticles topically before applying laser heat, selectively targeting and reducing sebaceous gland activity across a broader area. The clinic notes significant improvements within six weeks of starting GTP treatment. Vbeam pulsed dye laser is added for inflammatory acne, targeting the blood vessels feeding inflamed spots and red, persistent marks left by prior breakouts. Its precision and tolerability make it suitable for ongoing use alongside other modalities. Q-Switch laser addresses the pigmentation component, treating the post-inflammatory hyperpigmentation (PIH) that follows healed acne lesions. HydraFacial Deep Pore Cleansing is included in some programmes as a maintenance treatment, removing excess sebum and dead skin cells that would otherwise contribute to further congestion. All treatment plans are physician-supervised, and patients with moderate-to-severe inflammatory acne may also receive prescription-strength topical or oral medications as part of the comprehensive programme.